The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, COPD exacerbation history groups were “mediocre” in ...
Dupilumab vs placebo was linked to improved health-related quality of life and respiratory symptoms in patients with COPD and T2 inflammation.
Chronic obstructive pulmonary disease (COPD) is a group of conditions that affect your lungs. COPD causes difficulty breathing, with symptoms that may progress over time. About 16 million ...
Patients with COPD plus a depression/anxiety disorder had poorer scores related to disease burden and health-related quality of life, according to data published in Chronic Obstructive Pulmonary ...